Drug Profile
Colesevelam - Sanofi
Alternative Names: Cholestagel; Colesevelam hydrochloride; GT 31104; Lodalis; WelChol; Welchol®Chewable BarLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Genzyme Corporation
- Developer Daiichi Sankyo Company; Sanofi
- Class Amines; Antihyperglycaemics; Antihyperlipidaemics; Digestion aids; Polymers
- Mechanism of Action Bile acid binding protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Type 2 diabetes mellitus